Previous 10 | Next 10 |
NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2021 after the c...
PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600 PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600 PR Newswire ...
Stocks are on the move after hours following the most recent changes from S&P Dow Jones Indices, starting with PTC. Currently a constituent of the S&P MidCap 400, PTC will move into the S&P 500 to replace Varian Medical Systems (VAR), which was acquired today by Siemens Healthinee...
Gainers: [[PGNY]] +7.9%. [[XELB]] +7.0%. [[IDYA]] +6.9%. [[LSCC]] +6.6%. [[DKNG]] +6.0%.Losers: [[SPNE]] -3.8%. [[DBVT]] -3.4%. [[SYBX]] -3.0%. [[SESN]] -2.6%. [[DSEY]] -2.5%. For further details see: PGNY, XELB, SPNE and SYBX among after-hours movers
Progyny ([[PGNY]] +5.3%) shares have surged ~89.4% over the past 12-month period. Yet the analysts at Bank of America have upgraded the stock to buy from neutral noting an ‘attractive’ entry point following the recent pullback.At ~7x 2022 EV/ revenue estimate, the price target i...
Progyny shares fall ([[PGNY]] -8.2%) after the company posted fourth-quarter results and disclosed its full-year forecast for 2021.Q4 revenue of $100.3M (+54.0% Y/Y), beats by $2.44M.2021 guidance: Revenue is projected to be $520M to $540M; Net income is projected to be $30.1M to $37.4M, or $...
Progyny, Inc. (PGNY) Q4 2020 Earnings Conference Call February 24, 2021, 04:45 PM ET Company Participants James Hart - Vice President of Investor Relations David Schlanger - Chief Executive Officer Pete Anevski - Chief Operating Officer Mark Livingston - Chief Financial Officer Conference Cal...
Progyny (PGNY): Q4 EPS of $0.07 may not be comparable to consensus of $0.07.Revenue of $100.3M (+54.0% Y/Y) beats by $2.44M.Press Release For further details see: Progyny EPS of $0.07
Reports Record Fourth Quarter Revenue of $100.3 Million Issues Revenue Guidance of $520.0 to $540.0 Million for 2021, Reflecting Growth of 51% to 57% NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertili...
[[ACA]], [[ACAD]], [[ADPT]], [[AGI]], [[AMED]], [[ANSS]], [[APA]], [[AWK]], [[BILI]], [[BKNG]], [[CCRN]], [[CDNA]], [[CHDN]], [[CNXN]], [[CW]], [[DDD]], [[DOOR]], [[DRH]], [[ECPG]], [[EPR]], [[ESI]], [[ESTC]], [[FATE]], [[FNF]], [[FTI]], [[GBT]], [[GEF]], [[GH]], [[HCC]], [[ICLR]], [[INGN]], ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended June 30, 2024 after the close of the market on Tuesday, August 6, 20...
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded...